Allurion Technologies, Inc. ("Allurion" or the "Company") , a company dedicated to ending obesity, today announced initial results on the combination of the Allurion Program with low-dose GLP-1 ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Allurion Technologies (ALUR – Research Report) ...

NATICK, Mass. - Allurion Technologies, Inc. (NYSE: ALUR), a medical company focused on obesity treatment currently trading near its 52-week low at $2.27, has announced promising initial results ...

Research analysts at Roth Capital dropped their Q1 2025 EPS estimates for Allurion Technologies in a research note issued to investors on Wednesday, March 5th. Roth Capital analyst J. Wittes now ...

Allurion Announces Initial Results on the ... in Lean Body Mass After 8 Months of Combined Therapy Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company ...

U.S. stock futures declined on Friday after tumbling in trade on Thursday. Futures of all four indices were lower in ...

NATICK, Mass., February 25, 2025--(BUSINESS WIRE)--Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity ...

Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced that it has received an Issue Notification from the U.S ...

NATICK, Mass., March 04, 2025--(BUSINESS WIRE)--Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity, today ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...